Alimera Sciences, Inc. (ALIM) Social Stream



Alimera Sciences, Inc. (ALIM): $3.51

-0.07 (-1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ALIMERA SCIENCES INC (ALIM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALIM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 1 $12 $12 $12 $3.54 238.98%
2022-02-25 1 $10 $10 $10 $3.54 182.49%
2022-05-10 1 $8 $8 $8 $3.54 125.99%
2022-11-15 1 $9 $9 $9 $3.54 154.24%
2022-11-21 1 $9 $4.5 $6.75 $3.54 90.68%

Price Target Last Issued November 15, 2022

The Trend in the Analyst Price Target


Over the past 16 months, ALIM's average price target has gone down $9.63.

Over the past 38 weeks, ALIM's average upside potential has been 82.83%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-25 1 10 10.0 10.00 4.70 112.77%
2022-05-10 1 8 8.0 8.00 4.41 81.41%
2022-07-28 1 9 9.0 9.00 5.33 68.86%
2022-11-15 1 9 9.0 9.00 4.69 91.9%
2022-11-21 1 9 4.5 6.75 4.24 59.2%

ALIM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ALIM's average broker recommendation rating improved by 1 over the prior 13 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ALIMERA SCIENCES INC's number of analysts covering the stock is higher than practically none of all US stocks.
  • ALIM has a lower variance in analysts' estimates than 26.63% of all US stocks.
  • ALIMERA SCIENCES INC's average analyst price target is greater than 81.16% of Healthcare stocks.
  • ALIMERA SCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 219.76% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALIMERA SCIENCES INC are MEIP, ONCT, and MTEM.

Is ALIM a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6501 seconds.